HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer.

Abstract
The effects of melatonin and the thiazolinidinedione derivative CGP 52608 on apoptosis of Colon 38 cancer cells were investigated. Male mice were implanted subcutaneously with a suspension of Colon 38 cells. Ten days after induction of tumors, the animals were treated with melatonin or CGP 52608. Both substances were given in subcutaneous injections in daily doses of 10 or 100 microg in the evening for 6 days. The control group received solvent. The apoptotic cells were visualized in paraffin sections by means of the transferase-mediated dUTPnick end-labeling method. Both treatments increased significantly and to the same degree the number of apoptotic cells in tumors. This finding confirms our earlier observation that melatonin exerts a pro-apoptotic effect on murine colonic cancer cells. Moreover, because CGP 52608 is a ligand of RZR/ROR receptors and the latter are considered by some investigators as nuclear binding sites for melatonin, our data suggest the involvement of these receptors in the pro-apoptotic effect of melatonin.
AuthorsK Winczyk, M Pawlikowski, M Karasek
JournalJournal of pineal research (J Pineal Res) Vol. 31 Issue 2 Pg. 179-82 (Sep 2001) ISSN: 0742-3098 [Print] England
PMID11555175 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ligands
  • Receptors, Cell Surface
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Melatonin
  • Thiazoles
  • Thiosemicarbazones
  • CGP 52608
  • Melatonin
Topics
  • Animals
  • Apoptosis (drug effects)
  • Colonic Neoplasms (drug therapy, metabolism, pathology)
  • Ligands
  • Male
  • Melatonin (pharmacology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Receptors, Cell Surface (metabolism)
  • Receptors, Cytoplasmic and Nuclear (metabolism)
  • Receptors, Melatonin
  • Thiazoles (pharmacology)
  • Thiosemicarbazones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: